CVS Health Corporation $CVS Stake Increased by The Manufacturers Life Insurance Company

Posted by Francis Steltz on Sep 12th, 2026

The Manufacturers Life Insurance Company increased its holdings in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 5.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,287,441 shares of the pharmacy operator’s stock after buying an additional 70,197 shares during the quarter. The Manufacturers Life Insurance Company owned 0.10% of CVS Health worth $133,186,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. Kilter Group LLC acquired a new stake in CVS Health during the 2nd quarter worth about $27,000. Beaird Harris Wealth Management LLC increased its holdings in shares of CVS Health by 201.0% in the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 195 shares during the period. J.Safra Asset Management Corp acquired a new position in shares of CVS Health in the 2nd quarter valued at about $30,000. Timbuktu Capital Management LLC purchased a new stake in shares of CVS Health in the second quarter worth approximately $31,000. Finally, Dunhill Financial LLC acquired a new stake in shares of CVS Health during the second quarter worth approximately $32,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 5th. Royal Bank Of Canada lifted their target price on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Morgan Stanley boosted their price target on shares of CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a report on Thursday, June 4th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $112.00 price target on shares of CVS Health in a research note on Wednesday. Finally, Bank of America lifted their price objective on CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, June 22nd. Twenty-two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $107.24.

Check Out Our Latest Research Report on CVS Health

CVS Health Price Performance

Shares of CVS opened at $94.62 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The firm has a market cap of $121.02 billion, a PE ratio of 25.03, a PEG ratio of 0.93 and a beta of 0.59. The firm’s 50 day moving average price is $99.92 and its 200 day moving average price is $90.77. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68.

CVS Health (NYSE:CVS – Get Free Report) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, research analysts expect that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio is presently 70.37%.

CVS Health Company Profile

(Free Report)

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.